Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency.
Mysore
V
V
Department of Dermatology and Genito Urinary Medicine, Al Nahdha Hospital, Sultanate of Oman.
al-Suwaid
A R
AR
D000293:Adolescent; D000328:Adult; D002991:Clofazimine / Q000627:therapeutic use*; D003622:Dapsone / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005260:Female; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000150:complications*; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use; D007918:Leprosy / Q000150:complications* / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009850:Oman; D017410:Practice Guidelines as Topic; D012293:Rifampin / Q000627:therapeutic use*; D014944:World Health Organization
D007917:Leprostatic Agents; D003622:Dapsone; D002991:Clofazimine; D012293:Rifampin